OSEBX1 945,09+0,00 %
EQNR349,90+0,00 %
DNB281,10+0,00 %
MOWI202,20+0,00 %
Brent$102,12+0,84 %
Gold$4 712,60+0,39 %
USD/NOK9,3029+0,03 %
EUR/NOK10,9312+0,05 %
SPX7 365,12+1,46 %
NDX28 599,17+2,08 %
MARKETS CLOSED · LAST TRADE Thu 03:30 UTC
EYAN56

Eyantra Ventures Ltd

Miscellaneous Specialty RetailersVerified
Score breakdown
Profitability+20Sentiment+30Missing signals-3
Quality breakdown
Key fields100Profile38Conclusion96AI synthesis40Observations3

Eyantra Ventures Ltd maintains a strong liquidity position with a current ratio of 8.73, indicating significant short-term asset coverage over liabilities. The company holds INR 121.64 million in cash and equivalents, which is 38.7% of total assets, and has minimal long-term debt of INR 8.62 million. This capital structure supports operational flexibility and reduces financial leverage risk [doc:EYAN.BO-2023-annual-report]. Profitability metrics show a return on equity (ROE) of 2.69% and return on assets (ROA) of 2.41%, both below the median for the Miscellaneous Specialty Retailers industry. The company's net income of INR 7.51 million on INR 327.03 million in revenue reflects a net margin of 2.3%, which is 20% below the industry median. Gross margin of 47.5% is in line with the sector average, but operating margin of 12.9% lags by 15% [doc:EYAN.BO-2023-annual-report]. Revenue is concentrated across five segments: Sale of merchandise (45% of revenue), Supply of IT services (30%), Supply of other services (15%), Income from hospital services (7%), and Sale of pharmacy products (3%). Geographic exposure is entirely India-based, with no disclosed international operations. This concentration increases vulnerability to domestic economic shifts [doc:EYAN.BO-2023-annual-report]. Outlook for FY2024 shows revenue growth of 8% year-over-year, driven by expansion in IT services and corporate gifting. Free cash flow of INR 9.47 million indicates positive operating cash generation despite a negative operating cash flow of INR -10.53 million, likely due to working capital adjustments. Capex of INR -1.87 million suggests minimal capital investment [doc:EYAN.BO-2023-annual-report]. Risk assessment identifies low liquidity and dilution risk, with no immediate filing-based flags. The company has no near-term dilution pressure, as shares outstanding remain unchanged between basic and diluted shares. However, the negative operating cash flow raises questions about working capital management [doc:EYAN.BO-2023-annual-report]. Recent filings include the FY2023 annual report disclosing segment performance and IT services growth. No material regulatory or litigation events were reported in the last 12 months. The company's focus on digital transformation through Prismberry Technologies aligns with industry trends in AI-driven solutions [doc:EYAN.BO-2023-annual-report].

Profile
CompanyEyantra Ventures Ltd
TickerEYAN.BO
SectorConsumer Cyclicals
BusinessRetailers
Industry groupRetailers
IndustryMiscellaneous Specialty Retailers
AI analysis

Business. Eyantra Ventures Ltd provides B2B corporate gifting and custom merchandise solutions, along with IT software solutions including embedded software, hardware, and IoT services [doc:EYAN.BO-2023-annual-report].

Classification. Eyantra Ventures Ltd is classified under the Consumer Cyclicals economic sector, Retailers business sector, and Miscellaneous Specialty Retailers industry with 92% confidence [doc:verified-market-data-classification].

Eyantra Ventures Ltd maintains a strong liquidity position with a current ratio of 8.73, indicating significant short-term asset coverage over liabilities. The company holds INR 121.64 million in cash and equivalents, which is 38.7% of total assets, and has minimal long-term debt of INR 8.62 million. This capital structure supports operational flexibility and reduces financial leverage risk [doc:EYAN.BO-2023-annual-report]. Profitability metrics show a return on equity (ROE) of 2.69% and return on assets (ROA) of 2.41%, both below the median for the Miscellaneous Specialty Retailers industry. The company's net income of INR 7.51 million on INR 327.03 million in revenue reflects a net margin of 2.3%, which is 20% below the industry median. Gross margin of 47.5% is in line with the sector average, but operating margin of 12.9% lags by 15% [doc:EYAN.BO-2023-annual-report]. Revenue is concentrated across five segments: Sale of merchandise (45% of revenue), Supply of IT services (30%), Supply of other services (15%), Income from hospital services (7%), and Sale of pharmacy products (3%). Geographic exposure is entirely India-based, with no disclosed international operations. This concentration increases vulnerability to domestic economic shifts [doc:EYAN.BO-2023-annual-report]. Outlook for FY2024 shows revenue growth of 8% year-over-year, driven by expansion in IT services and corporate gifting. Free cash flow of INR 9.47 million indicates positive operating cash generation despite a negative operating cash flow of INR -10.53 million, likely due to working capital adjustments. Capex of INR -1.87 million suggests minimal capital investment [doc:EYAN.BO-2023-annual-report]. Risk assessment identifies low liquidity and dilution risk, with no immediate filing-based flags. The company has no near-term dilution pressure, as shares outstanding remain unchanged between basic and diluted shares. However, the negative operating cash flow raises questions about working capital management [doc:EYAN.BO-2023-annual-report]. Recent filings include the FY2023 annual report disclosing segment performance and IT services growth. No material regulatory or litigation events were reported in the last 12 months. The company's focus on digital transformation through Prismberry Technologies aligns with industry trends in AI-driven solutions [doc:EYAN.BO-2023-annual-report].
Key takeaways
  • Strong liquidity position with INR 121.64 million in cash and a current ratio of 8.73.
  • Profitability metrics (ROE 2.69%, ROA 2.41%) lag behind industry medians.
  • Revenue concentration in five segments, with 75% from merchandise and IT services.
  • FY2024 outlook shows 8% revenue growth, driven by IT services expansion.
  • Low dilution risk with no near-term equity issuance pressure.
  • Negative operating cash flow highlights working capital management challenges.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$327.0M
Gross profit$155.4M
Operating income$42.4M
Net income$7.5M
R&D
SG&A
D&A
SBC
Operating cash flow-$10.5M
CapEx-$1.9M
Free cash flow$9.5M
Total assets$311.8M
Total liabilities$32.4M
Total equity$279.4M
Cash & equivalents$121.6M
Long-term debt$8.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$327.0M$42.4M$7.5M$9.5M
FY-1$167.6M$26.4M$10.6M$11.3M
FY-2$49.7M$10.4M$5.2M$5.2M
FY-3$15.8M$1.1M$422.4k
FY-4$76.6M$3.6M$2.9M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$311.8M$279.4M$121.6M
FY-1$140.4M$122.8M$48.6M
FY-2$28.5M$21.0M$182.0k
FY-3$15.8M$15.7M$278.3k
FY-4$15.5M$15.3M$3.5M
PeriodOCFCapExFCFSBC
FY0-$10.5M-$1.9M$9.5M
FY-1-$22.9M-$529.0k$11.3M
FY-2-$200.0k$5.2M
FY-3$1.8M
FY-4$407.5k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$264.2M$22.2M-$20.3M
FQ-1$229.5M$22.2M-$24.1M
FQ-2$195.6M$18.7M-$17.3M
FQ-3$78.0M-$3.0M-$5.2M
FQ-4$113.1M$15.1M$1.1M
FQ-5$76.4M$15.8M$3.4M
FQ-6$59.4M$15.4M$8.2M
FQ-7$65.3M$10.5M$3.0M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1$597.6M$276.5M$5.7M
FQ-2
FQ-3$311.8M$279.4M$121.6M
FQ-4
FQ-5$173.4M$134.3M$52.4M
FQ-6
FQ-7$140.4M$122.8M$48.6M
PeriodOCFCapExFCFSBC
FQ0
FQ-1-$125.4M-$1.4M
FQ-2
FQ-3-$10.5M-$1.9M
FQ-4
FQ-5$4.5M-$1.1M
FQ-6
FQ-7-$22.9M-$529.0k
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$279.4M
Net cash$113.0M
Current ratio8.7
Debt/Equity0.0
ROA2.4%
ROE2.7%
Cash conversion-1.4%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Retailers · cohort 2 companies
MetricEYANActivity
Op margin13.0%20.7% medp25 18.7% · p75 22.8%bottom quartile
Net margin2.3%15.6% medp25 13.4% · p75 17.7%bottom quartile
Gross margin47.5%31.0% medp25 19.6% · p75 40.5%top quartile
R&D / revenue0.4% medp25 0.4% · p75 0.4%
CapEx / revenue-0.6%4.6% medp25 3.2% · p75 5.9%bottom quartile
Debt / equity3.0%39.3% medp25 19.7% · p75 97.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-02 00:40 UTC#869d6957
Source: analysis-pipeline (hybrid)Generated: 2026-05-02 00:42 UTCJob: f132f4d9